<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The massive amounts of <z:chebi fb="0" ids="27389">beta-aminoisobutyric acid</z:chebi> (beta-AIBA) in the urine of Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> patients were measured along with other <z:chebi fb="0" ids="33704">alpha-amino acids</z:chebi> and <z:chebi fb="0" ids="16958">beta-alanine</z:chebi> present in <z:mpath ids='MPATH_458'>normal</z:mpath> and decreased levels </plain></SENT>
<SENT sid="1" pm="."><plain>The ratios of the amount of beta-AIBA to <z:chebi fb="0" ids="16958">beta-alanine</z:chebi>, in mumoles/kg urine collected in 24 hours, were elevated for <z:hpo ids='HP_0000001'>all</z:hpo> patients </plain></SENT>
<SENT sid="2" pm="."><plain>The degree of elevation of beta-AIBA excretion and the ratio of the two <z:chebi fb="0" ids="33706">beta-amino acids</z:chebi> appeared to be related to the amount of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> mass present </plain></SENT>
<SENT sid="3" pm="."><plain>These analyses may have possible value in monitoring patients with Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> during their disease course </plain></SENT>
</text></document>